Trad Wadsworth

761 total citations
7 papers, 561 citations indexed

About

Trad Wadsworth is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Trad Wadsworth has authored 7 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 3 papers in Otorhinolaryngology. Recurrent topics in Trad Wadsworth's work include Head and Neck Cancer Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). Trad Wadsworth is often cited by papers focused on Head and Neck Cancer Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). Trad Wadsworth collaborates with scholars based in United States and Switzerland. Trad Wadsworth's co-authors include Fadlo R. Khuri, Jonathan J. Beitler, Nabil F. Saba, Dong M. Shin, Taofeek K. Owonikoko, William Grist, Michael Goodman, Scott A. Kono, Amy Y. Chen and Suresh S. Ramalingam and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Acta Oncologica.

In The Last Decade

Trad Wadsworth

7 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Trad Wadsworth United States	6	412	311	245	113	75	7	561
Akihiro Terada Japan	15	393 1.0×	330 1.1×	279 1.1×	67 0.6×	48 0.6×	37	591
Cesare Grandi Italy	9	476 1.2×	410 1.3×	426 1.7×	60 0.5×	95 1.3×	19	744
Rina Jiromaru Japan	11	203 0.5×	196 0.6×	137 0.6×	58 0.5×	39 0.5×	32	357
A. Benlyazid France	9	175 0.4×	206 0.7×	101 0.4×	116 1.0×	67 0.9×	17	442
Masamune Takeda Japan	13	219 0.5×	306 1.0×	295 1.2×	57 0.5×	37 0.5×	26	536
Chihiro Fushimi Japan	11	348 0.8×	377 1.2×	140 0.6×	45 0.4×	28 0.4×	36	498
Tatsuo Masubuchi Japan	11	449 1.1×	419 1.3×	120 0.5×	69 0.6×	35 0.5×	38	582
G. Scaramellini Italy	11	284 0.7×	209 0.7×	282 1.2×	25 0.2×	48 0.6×	21	487
Sandhya Gokavarapu India	13	150 0.4×	114 0.4×	128 0.5×	99 0.9×	85 1.1×	34	398
Mauro Marques Barbosa Brazil	9	280 0.7×	221 0.7×	227 0.9×	69 0.6×	43 0.6×	12	442

Countries citing papers authored by Trad Wadsworth

Since Specialization

Citations

This map shows the geographic impact of Trad Wadsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trad Wadsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trad Wadsworth more than expected).

Fields of papers citing papers by Trad Wadsworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trad Wadsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trad Wadsworth. The network helps show where Trad Wadsworth may publish in the future.

Co-authorship network of co-authors of Trad Wadsworth

This figure shows the co-authorship network connecting the top 25 collaborators of Trad Wadsworth. A scholar is included among the top collaborators of Trad Wadsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trad Wadsworth. Trad Wadsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Saba, Nabil F., Selwyn J. Hurwitz, Kelly R. Magliocca, et al.. (2014). Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck. Cancer. 120(24). 3940–3951. 47 indexed citations

2.

Saba, Nabil F., Scott A. Kono, Selwyn J. Hurwitz, et al.. (2013). Carboplatin (C), cetuximab (Cet), and everolimus (E) in recurrent or metastatic squamous cell carcinoma of the head and neck (RMSCCHN). Results of a phase Ib study.. Journal of Clinical Oncology. 31(15_suppl). 6083–6083. 2 indexed citations

3.

Ansa, Benjamin E., Michael Goodman, Kevin C. Ward, et al.. (2013). Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer. 119(14). 2602–2610. 149 indexed citations

4.

Goodman, Michael, Scott A. Kono, William Grist, et al.. (2012). Adenoid cystic carcinoma of the head and neck. Cancer. 118(18). 4444–4451. 261 indexed citations

5.

Saba, Nabil F., Michael Goodman, Kevin C. Ward, et al.. (2011). Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based Analysis. Oncology. 81(1). 12–20. 88 indexed citations

6.

Sandhu, Ajay, Nikhil G. Rao, Shankar Giri, et al.. (2008). Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: How much is enough?. Acta Oncologica. 47(5). 948–953. 6 indexed citations

7.

Saha, Anutosh Ranjan, et al.. (1991). Methyl inosine monophosphate (MIMP) promotes immune responses in mice. International Journal of Immunopharmacology. 13(6). 761–761. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact